A small‐molecule inhibitor of NF‐κB‐inducing kinase (NIK) protects liver from toxin‐induced inflammation, oxidative stress, and injury
dc.contributor.author | Ren, Xiaomeng | |
dc.contributor.author | Li, Xinzhi | |
dc.contributor.author | Jia, Linna | |
dc.contributor.author | Chen, Deheng | |
dc.contributor.author | Hou, Hai | |
dc.contributor.author | Rui, Liangyou | |
dc.contributor.author | Zhao, Yujun | |
dc.contributor.author | Chen, Zheng | |
dc.date.accessioned | 2020-03-17T18:32:00Z | |
dc.date.available | 2020-03-17T18:32:00Z | |
dc.date.issued | 2017-02 | |
dc.identifier.citation | Ren, Xiaomeng; Li, Xinzhi; Jia, Linna; Chen, Deheng; Hou, Hai; Rui, Liangyou; Zhao, Yujun; Chen, Zheng (2017). "A small‐molecule inhibitor of NF‐κB‐inducing kinase (NIK) protects liver from toxin‐induced inflammation, oxidative stress, and injury." The FASEB Journal 31(2): 711-718. | |
dc.identifier.issn | 0892-6638 | |
dc.identifier.issn | 1530-6860 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/154426 | |
dc.description.abstract | Potent and selective chemical probes are valuable tools for discovery of novel treatments for human diseases. NF‐κβ‐inducing kinase (NIK) is a key trigger in the development of liver injury and fibrosis. Whether inhibition of NIK activity by chemical probes ameliorates liver inflammation and injury is largely unknown. In this study, a small‐molecule inhibitor of NIK, B022, was found to be a potent and selective chemical probe for liver inflammation and injury. B022 inhibited the NIK signaling pathway, including NIK‐induced p100‐to‐p52 processing and inflammatory gene expression, both in vitro and in vivo. Furthermore, in vivo administration of B022 protected against not only NIK but also CCl4‐induced liver inflammation and injury. Our data suggest that inhibition of NIK is a novel strategy for treatment of liver inflammation, oxidative stress, and injury.—Ren, X., Li, X., Jia, L., Chen, D., Hou, H., Rui, L., Zhao, Y., Chen, Z. A small‐molecule inhibitor of NF‐κβ‐inducing kinase (NIK) protects liver from toxin‐induced inflammation, oxidative stress, and injury. FASEB J. 31, 711–718 (2017). http://www.fasebj.org | |
dc.publisher | Federation of American Societies for Experimental Biology | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | inflammation | |
dc.subject.other | CCl4 | |
dc.subject.other | NIK | |
dc.subject.other | liver injury | |
dc.title | A small‐molecule inhibitor of NF‐κB‐inducing kinase (NIK) protects liver from toxin‐induced inflammation, oxidative stress, and injury | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Biology | |
dc.subject.hlbtoplevel | Science | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/154426/1/fsb2fasebj3120840r.pdf | |
dc.identifier.doi | 10.1096/fj.201600840R | |
dc.identifier.source | The FASEB Journal | |
dc.identifier.citedreference | Chen, Z., Morris, D. L., Jiang, L., Liu, Y., and Rui, L. ( 2014 ) SH2B1 in β‐cells promotes insulin expression and glucose metabolism in mice. Mol. Endocrinol. 28, 696 – 705 | |
dc.identifier.citedreference | Berger, M. L., Bhatt, H., Combes, B., and Estabrook, R. W. ( 1986 ) CCl4‐induced toxicity in isolated hepatocytes: the importance of direct solvent injury. Hepatology 6, 36 – 45 | |
dc.identifier.citedreference | Lee, I.‐C., Kim, S.‐H., Baek, H.‐S., Moon, C., Kang, S.‐S., Kim, S.‐H., Kim, Y.‐B., Shin, I.‐S., and Kim, J.‐C. ( 2014 ) The involvement of Nrf2 in the protective effects of diallyl disulfide on carbon tetrachloride‐induced hepatic oxidative damage and inflammatory response in rats. Food Chem. Toxicol. 63, 174 – 185 | |
dc.identifier.citedreference | Kovalovich, K., DeAngelis, R. A., Li, W., Furth, E. E., Ciliberto, G., and Taub, R. ( 2000 ) Increased toxin‐induced liver injury and fibrosis in interleukin‐6‐deficient mice. Hepatology 31, 149 – 159 | |
dc.identifier.citedreference | Czaja, M. J., Xu, J., and Alt, E. ( 1995 ) Prevention of carbon tetrachloride‐induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 108, 1849 – 1854 | |
dc.identifier.citedreference | Slater, T. F. ( 1966 ) Necrogenic action of carbon tetrachloride in the rat: a speculative mechanism based on activation. Nature 209, 36 – 40 | |
dc.identifier.citedreference | Shi, J., Aisaki, K., Ikawa, Y., and Wake, K. ( 1998 ) Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. Am. J. Pathol. 153, 515 – 525 | |
dc.identifier.citedreference | Shen, H., Sheng, L., Chen, Z., Jiang, L., Su, H., Yin, L., Omary, M. B., and Rui, L. ( 2014 ) Mouse hepatocyte overexpression of NF‐κB inducing kinase (NIK) triggers fatal macrophage‐dependent liver injury and fibrosis. Hepatology 60, 2065 – 2076 | |
dc.identifier.citedreference | Jiang, B., Shen, H., Chen, Z., Yin, L., Zan, L., and Rui, L. ( 2015 ) Carboxyl terminus of HSC70‐interacting protein (CHIP) down‐regulates NF‐κβ‐inducing kinase (NIK) and suppresses NIK‐induced liver injury. J. Biol. Chem. 290, 11704–11714 | |
dc.identifier.citedreference | Xiao, G., Fong, A., and Sun, S.‐C. ( 2004 ) Induction of p100 processing by NF‐kappaβ‐inducing kinase involves docking IkappaB kinase a (IKKalpha) to p100 and IKKalpha‐mediated phosphorylation. J. Biol. Chem. 279, 30099–30105 | |
dc.identifier.citedreference | Xiao, G., Harhaj, E. W., and Sun, S. C. ( 2001 ) NF‐kappa β‐inducing kinase regulates the processing of NF‐kappaB2 p100. Mol. Cell 7, 401 – 409 | |
dc.identifier.citedreference | Senftleben, U., Cao, Y., Xiao, G., Greten, F. R., Krähn, G., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S. C., and Karin, M. ( 2001 ) Activation by IKKalpha of a second, evolutionary conserved, NF‐kappa B signaling pathway. Science 293, 1495 – 1499 | |
dc.identifier.citedreference | Sun, S. C. ( 2011 ) Non‐canonical NF‐κB signaling pathway. Cell Res. 21, 71 – 85 | |
dc.identifier.citedreference | De Leon‐Boenig, G., Bowman, K. K., Feng, J. A., Crawford, T., Everett, C., Franke, Y., Oh, A., Stanley, M., Staben, S. T., Starovasnik, M. A., Wallweber, H. J., Wu, J., Wu, L. C., Johnson, A. R., and Hymowitz, S. G. ( 2012 ) The crystal structure of the catalytic domain of the NF‐κB inducing kinase reveals a narrow but ~exible active site. Structure 20, 1704 – 1714 | |
dc.identifier.citedreference | Demchenko, Y. N., Brents, L. A., Li, Z., Bergsagel, L. P., McGee, L. R., and Kuehl, M. W. ( 2014 ) Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase‐dependent activation of NFkB. Oncotarget 5, 4554 – 4566 | |
dc.identifier.citedreference | Chen, G., Cushing, T. D., Fisher, B., He, X., Li, K., Li, Z., McGee, L. R., Pattaropong, V., Faulder, P., Seganish, J. L., Shin, Y. Alkylnyl alcohols as kinase inhibitors. PCT Patent Publication WO 2009159011, December 30, 2009 | |
dc.identifier.citedreference | Qin, W., Li, X., Xie, L., Li, S., Liu, J., Jia, L., Dong, X., Ren, X., Xiao, J., Yang, C., Zhou, Y., and Chen, Z. ( 2016 ) A long non‐coding RNA, APOA4‐AS, regulates APOA4 expression depending on HuR in mice. Nucleic Acids Res. 44, 6423 – 6433 | |
dc.identifier.citedreference | Chen, Z., Canet, M. J., Sheng, L., Jiang, L., Xiong, Y., Yin, L., and Rui, L. ( 2015 ) Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity. Mol. Metab. 4, 951 – 960 | |
dc.identifier.citedreference | Chen, Z., Sheng, L., Shen, H., Zhao, Y., Wang, S., Brink, R., and Rui, L. ( 2012 ) Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses. Diabetes 61, 566 – 573 | |
dc.identifier.citedreference | Chen, Z., Shen, H., Sun, C., Yin, L., Tang, F., Zheng, P., Liu, Y., Brink, R., and Rui, L. ( 2015 ) Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity. Am. J. Physiol. Endocrinol. Metab. 308, E460 – E469 | |
dc.identifier.citedreference | Chen, Z., Morris, D. L., Jiang, L., Liu, Y., and Rui, L. ( 2014 ) SH2B1 in β‐cells regulates glucose metabolism by promoting β‐cellsurvivaland islet expansion. Diabetes 63, 585 – 595 | |
dc.identifier.citedreference | Cubero, F. J., Zhao, G., Nevzorova, Y. A., Hatting, M., Al Masaoudi, M., Verdier, J., Peng, J., Schaefer, F. M., Hermanns, N., Boekschoten, M. V., Grouls, C., Gassler, N., Kiessling, F., Muller, M., Davis, R. J., Liedtke, C., and Trautwein, C. ( 2015 ) Haematopoietic cell‐derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury. J. Hepatol. 62, 140 – 149 | |
dc.identifier.citedreference | Kluwe, J., Pradere, J.‐P., Gwak, G.‐Y., Mencin, A., De Minicis, S., Osterreicher, C. H., Colmenero, J., Bataller, R., and Schwabe, R. F. ( 2010 ) Modulation of hepatic fibrosis by c‐Jun‐N‐terminal kinase inhibition. Gastroenterology 138, 347 – 359 | |
dc.identifier.citedreference | Armendáriz‐Borunda, J., Islas‐Carbajal, M. C., Meza‐García, E., Rincón, A. R., Lucano, S., Sandoval, A. S., Salazar, A., Berumen, J., Alvarez, A., Covarrubias, A., Aréchiga, G., and García, L. ( 2006 ) A pilot study in patients with established advanced liver fibrosis using pirfenidone. Gut 55, 1663 – 1665 | |
dc.identifier.citedreference | Fagone, P., Mangano, K., Pesce, A., Portale, T. R., Puleo, S., and Nicoletti, F. ( 2016 ) Emerging therapeutic targets for the treatment of hepatic fibrosis. Drug Discov. Today 21, 369 – 375 | |
dc.identifier.citedreference | Rockey, D. C., and Chung, J. J. ( 1994 ) Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis. J. Investig. Med. 42, 660 – 670 | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.